Robert Redner
Physician · Upmc
Credentials: · · · · ·
History
- Present
- 1983–1986
Hematology and Medical Oncology
- 1980–1983
Internal Medicine
- 1976–1980
Research
The Lancet · 2008 · 669 citations
Molecular and Cellular Biology · 1988 · 530 citations
Proceedings of the National Academy of Sciences of the United States of America · 1998 · 450 citations
- MB
20 papers
- AR
18 papers
- MA
18 papers
- JH
17 papers
14 papers
- KD
13 papers
12 papers
- RF
12 papers
Grants
- 2016–2019
SFK-Inhibitor Enhancement of ATRA-Mediated Differentiation of APL
National Cancer Institute · R21
Contact PI · $370.1K · University of Pittsburgh at Pittsburgh
- 1995–2012
Characterization of a Novel Translocation Product in APL
National Cancer Institute · R01
Contact PI · $914.2K · University of Pittsburgh at Pittsburgh
- 2002–2007
Vitamin D and Dexamethasone in Myelodysplastic Syndromes
National Cancer Institute · R21
Contact PI · $664.4K · University of Pittsburgh at Pittsburgh
- 2001–2006
Calcitriol & Dexamethasone for Myelodysplastic Syndromes
Food and Drug Administration · R01
Contact PI · $425.5K · University of Pittsburgh at Pittsburgh
Clinical trials
- 2011–2016
Principal investigator · Completed · Phase 1
University of Pittsburgh
- 2008–2015
Principal investigator · Completed · Phase 1
Robert Redner, MD
- 2026–2030
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)